Beyond the JAK2 mutation: The inflammasome, clonal stability, and the thrombotic niche in myeloproliferative neoplasms.
Inflammation and the microenvironment beyond a single genetic mutation explain blood clots in bone marrow disorders, revealing new therapeutic targets.
The thrombotic niche model expands mechanistic understanding of MPN-associated thrombosis beyond JAK2 to include inflammasome and clonal microenvironment factors that could serve as new therapeutic targets. The framework may identify patients at thrombotic risk despite JAK2-negative status.
What the study was
- Study design
- Narrative review
- Population
- Myeloproliferative neoplasm (MPN) patients
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Clinical and experimental medicine
Why it surfaced
Novel MPN thrombotic niche model; narrative review only; high conceptual novelty without empirical data.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.